Tumor Immunotherapy Using A2A Adenosine Receptor Antagonists

被引：20
|
作者：
Zhang, Jinfeng [1 ,2 ]
Yan, Wenzhong [1 ]
Duan, Wenwen [1 ]
Wuthrich, Kurt [1 ,3 ]
Cheng, Jianjun [1 ]
机构：
[1] ShanghaiTech Univ, IHuman Inst, Shanghai 201210, Peoples R China
[2] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China
[3] Scripps Res, Dept Integrated Struct & Computat Biol, La Jolla, CA 92037 USA
来源：
PHARMACEUTICALS | 2020年 / 13卷 / 09期
关键词：
GPCR; immuno-oncology; Parkinson's disease; drug binding modes; cancer therapy; PARKINSONS-DISEASE; CRYSTAL-STRUCTURE; DERIVATIVES; ZM241385; POTENT; ZM-241385; BLOCKADE; BINDING; CELLS;
D O I：
10.3390/ph13090237
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
The A(2A) adenosine receptor (A(2A) AR) plays critical roles in human physiology and pathophysiology, which makes it an important drug target. Previous drug-discovery efforts targeting the A(2A) AR have been focused on the use of A(2A) AR antagonists for the treatment of Parkinson's disease. More recently, the A(2A) AR has attracted additional attention for its roles in immuno-oncology, and a number of A(2A) AR antagonists are currently used as lead compounds for antitumor drugs in both preclinical models and clinical trials. This review surveys recent advances in the development of A(2A) AR antagonists for cancer immunotherapy. The therapeutic potential of representative A(2A) AR antagonists is discussed based on both animal efficacy studies and clinical data.
引用
收藏
页码：1 / 14
页数：14
相关论文
共 50 条
  • [1] Towards Next Generation Adenosine A2A Receptor Antagonists
    Yuan, G.
    Jones, G. B.
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (34) : 3918 - 3935
  • [2] Pharmacophore modeling of human adenosine receptor A2A antagonists
    Xu, Zhejun
    Cheng, Feixiong
    Da, Chenxiao
    Liu, Guixia
    Tang, Yun
    JOURNAL OF MOLECULAR MODELING, 2010, 16 (12) : 1867 - 1876
  • [3] A2A Adenosine Receptor Antagonists and their Potential in Neurological Disorders
    Lambertucci, Catia
    Marucci, Gabriella
    Catarzi, Daniela
    Colotta, Vittoria
    Francucci, Beatrice
    Spinaci, Andrea
    Varano, Flavia
    Volpini, Rosaria
    CURRENT MEDICINAL CHEMISTRY, 2022, 29 (28) : 4780 - 4795
  • [4] Adenosine A2A Receptor Antagonists and Parkinson's Disease
    Shook, Brian C.
    Jackson, Paul F.
    ACS CHEMICAL NEUROSCIENCE, 2011, 2 (10): : 555 - 567
  • [5] Enhancement of tumor immunotherapy by deletion of the A2A adenosine receptor
    Waickman, Adam T.
    Alme, Angela
    Senaldi, Liana
    Zarek, Paul E.
    Horton, Maureen
    Powell, Jonathan D.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2012, 61 (06) : 917 - 926
  • [6] A2A Adenosine Receptor Antagonists as Therapeutic Candidates: Are They Still an Interesting Challenge?
    Cacciari, Barbara
    Spalluto, Giampiero
    Federico, Stephanie
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2018, 18 (14) : 1168 - 1174
  • [7] Discovery of 2-aminoimidazopyridine adenosine A2A receptor antagonists
    McGuinness, Brian F.
    Cole, Andrew G.
    Dong, Guizhen
    Brescia, Marc-Raleigh
    Shao, Yuefei
    Henderson, Ian
    Rokosz, Laura L.
    Stauffer, Tara M.
    Mannava, Neelima
    Kimble, Earl F.
    Hicks, Catherine
    White, Nicole
    Wines, Pamela G.
    Quadros, Elizabeth
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (22) : 6845 - 6849
  • [8] Development of Adenosine A2A Receptor Antagonists for the Treatment of Parkinson's Disease: A Recent Update and Challenge
    Zheng, Jiyue
    Zhang, Xiaohu
    Zhen, Xuechu
    ACS CHEMICAL NEUROSCIENCE, 2019, 10 (02): : 783 - 791
  • [9] A2A Adenosine Receptor Antagonists: Are Triazolotriazine and Purine Scaffolds Interchangeable?
    Spinaci, Andrea
    Lambertucci, Catia
    Buccioni, Michela
    Dal Ben, Diego
    Graiff, Claudia
    Barbalace, Maria Cristina
    Hrelia, Silvana
    Angeloni, Cristina
    Tayebati, Seyed Khosrow
    Ubaldi, Massimo
    Masi, Alessio
    Klotz, Karl-Norbert
    Volpini, Rosaria
    Marucci, Gabriella
    MOLECULES, 2022, 27 (08):
  • [10] Discovery of aminoquinazoline derivatives as human A2A adenosine receptor antagonists
    Zhou, Gang
    Aslanian, Robert
    Gallo, Gioconda
    Khan, Tanweer
    Kuang, Rongze
    Purakkattle, Biju
    De Ruiz, Manuel
    Stamford, Andrew
    Ting, Pauline
    Wu, Heping
    Wang, Hongwu
    Xiao, Dong
    Yu, Tao
    Zhang, Yonglian
    Mullins, Deborra
    Hodgson, Robert
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (04) : 1348 - 1354
12345